These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27771978)

  • 1. Challenges and opportunities in the treatment of ventilator-associated pneumonia.
    Schreiber MP; Shorr AF
    Expert Rev Anti Infect Ther; 2017 Jan; 15(1):23-32. PubMed ID: 27771978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
    Hellyer TP; Anderson NH; Parker J; Dark P; Van Den Broeck T; Singh S; McMullan R; Agus AM; Emerson LM; Blackwood B; Gossain S; Walsh TS; Perkins GD; Conway Morris A; McAuley DF; Simpson AJ
    Trials; 2016 Jul; 17(1):318. PubMed ID: 27422026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
    Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
    Trials; 2015 Mar; 16():102. PubMed ID: 25872790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
    Wongsurakiat P; Tulatamakit S
    Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of ventilator-associated pneumonia.
    Diaz E; Ulldemolins M; Lisboa T; Rello J
    Infect Dis Clin North Am; 2009 Sep; 23(3):521-33. PubMed ID: 19665081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventilator-associated pneumonia in injured patients: do you trust your Gram's stain?
    Davis KA; Eckert MJ; Reed RL; Esposito TJ; Santaniello JM; Poulakidas S; Luchette FA
    J Trauma; 2005 Mar; 58(3):462-6; discussion 466-7. PubMed ID: 15761337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: risk factors and impact on outcomes.
    Piskin N; Aydemir H; Oztoprak N; Akduman D; Comert F; Kokturk F; Celebi G
    BMC Infect Dis; 2012 Oct; 12():268. PubMed ID: 23095664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
    Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
    Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.
    Bassetti M; Taramasso L; Giacobbe DR; Pelosi P
    Expert Rev Anti Infect Ther; 2012 May; 10(5):585-96. PubMed ID: 22702322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do guidelines change outcomes in ventilator-associated pneumonia?
    Bassi GL; Ferrer M; Saucedo LM; Torres A
    Curr Opin Infect Dis; 2010 Apr; 23(2):171-7. PubMed ID: 20134322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for hospital-acquired pneumonia.
    Liapikou A; Rosales-Mayor E; Torres A
    Expert Opin Pharmacother; 2014 Apr; 15(6):775-86. PubMed ID: 24579912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
    J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli.
    Hedrick TL; McElearney ST; Smith RL; Evans HL; Pruett TL; Sawyer RG
    Surg Infect (Larchmt); 2007 Dec; 8(6):589-97. PubMed ID: 18171118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria.
    Kollef KE; Schramm GE; Wills AR; Reichley RM; Micek ST; Kollef MH
    Chest; 2008 Aug; 134(2):281-287. PubMed ID: 18682456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bradley JS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.